Reata Pharmaceuticals, Inc. (NASDAQ:RETA)

About the company

Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by W. Christian Wigley, Waldemar Priebe, Philip J. Thomas, Jef Karel de Brabander, Thomas C. Südhof, Jonathan M. Graff and J. Warren Huff on September 1, 2002 and is headquartered in Irving, TX.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

220

CEO

J. Warren Huff

Exchange

NASDAQ

Website

http://www.reatapharma.com

$15.00M

Total Revenue

220

Employees

$4B

Market Capitalization

-10.69

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$-55M

Operating Margin (in %)

Total operating margin

$-22M

Net Margin (in %)

Total net margin

$-23M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Johnson & Johnson JNJ 369559.56 80856.00 5.65 21.75 21.01
Pfizer Inc. PFE 199512.60 49197.00 3.06 14.01 28.80
Merck & Co., Inc. MRK 194487.54 47194.00 6.97 18.54 22.20
AbbVie, Inc. ABBV 122908.23 36227.00 9.66 17.61 19.06
Eli Lilly & Co. LLY 120017.34 22949.00 30.68 21.18 24.48
Bristol Myers Squibb Co. BMY 116906.24 34862.00 2.65 -199.17 -1.61
Royalty Pharma Plc RPRX 21924.84 1922.00 5.27 31.14 36.50
Repligen Corp. RGEN 8902.40 302.00 8.17 300.35 10.23
Biohaven Pharmaceutical Holding Co. Ltd. BHVN 4266.90 11.00 -131.49 -7.08 None
Allakos, Inc. ALLK 4034.40 None 9.20 -35.61 None
Turning Point Therapeutics, Inc. TPTX 3759.12 None 6.19 -31.93 None
Reata Pharmaceuticals, Inc. RETA 3740.48 15.00 16.97 -10.69 -150.30
Principia Biopharma, Inc. PRNB 3001.50 50.00 9.47 -40.51 -137.82
Nektar Therapeutics NKTR 2816.07 163.00 2.27 -6.55 -264.25
Springworks Therapeutics, Inc. SWTX 2546.25 None 9.90 -37.24 None
OPKO Health, Inc. OPK 2492.00 966.00 1.69 -12.12 -20.69
Apellis Pharmaceuticals, Inc. APLS 2232.15 None 10.54 -4.80 None
Ra Pharmaceuticals, Inc. RARX 2111.78 3.00 8.68 -20.78 -585.71
ADC Therapeutics SA ADCT 2029.89 2.00 11.17 -8.53 None
Karuna Therapeutics, Inc. KRTX 2004.75 None 5.74 0.16 None
Forma Therapeutics Holdings, Inc. FMTX 1960.20 11.00 4.43 -34.80 -513.80
Harmony Biosciences Holdings, Inc. HRMY 1940.40 64.00 -50.77 -20.00 -141.54
Zymeworks, Inc. ZYME 1874.36 30.00 3.70 -10.17 -569.13
Akcea Therapeutics, Inc. AKCA 1817.00 337.00 3.86 -49.11 -12.34
IGM Biosciences, Inc. IGMS 1712.75 None 8.19 -27.49 None
Y-mAbs Therapeutics, Inc. YMAB 1635.14 None 11.79 -14.44 None
Y-mAbs Therapeutics, Inc. YMAB 1587.64 None 11.45 -14.02 None
Keros Therapeutics, Inc. KROS 1264.20 5.00 9.02 -43.90 -581.22
Generation Bio Co. GBIO 1090.35 0.00 3.70 -16.15 None
Quanterix Corp. QTRX 1075.76 60.00 10.88 -24.01 -74.92
Nurix Therapeutics, Inc. NRIX 1025.70 13.00 3.32 -27.68 -283.59
Phathom Pharmaceuticals, Inc. PHAT 951.08 None 4.97 -4.52 None
Kiniksa Pharmaceuticals Ltd. KNSA 941.92 None 4.56 -7.72 None
Repare Therapeutics, Inc. RPTX 935.73 None 2.96 -23.86 None
Athenex, Inc. ATNX 910.40 141.00 7.64 -7.90 -82.63
Krystal Biotech, Inc. KRYS 825.12 None 2.91 -37.27 None
Constellation Pharmaceuticals, Inc. CNST 819.00 None 2.29 -8.15 None
Arcutis Biotherapeutics, Inc. ARQT 764.94 None 4.20 -8.39 None
Arcturus Therapeutics Holdings, Inc. ARCT 760.65 11.00 13.27 -19.43 -341.76
Annexon, Inc. ANNX 737.18 None -7.70 -19.49 None
Akero Therapeutics, Inc. AKRO 734.44 None 8.77 7.69 None
Phibro Animal Health Corp. PAHC 703.97 800.00 3.69 20.69 4.19
Provention Bio, Inc. PRVB 669.94 None 10.60 -15.13 None
Provention Bio, Inc. PRVB 651.88 None 10.31 -14.72 None
Amneal Pharmaceuticals, Inc. AMRX 646.09 1739.00 2.20 -2.95 -11.16
Biospecifics Technologies Corp. BSTC 616.98 35.00 5.00 35.54 52.45
Oric Pharmaceuticals, Inc. ORIC 615.00 None 3.24 -17.67 None
Ocular Therapeutix, Inc. OCUL 585.27 7.00 132.71 -4.67 None
Gossamer Bio, Inc. GOSS 562.28 None 1.53 -2.49 None
SIGA Technologies, Inc. SIGA 525.62 55.00 5.30 106.83 11.35
Fusion Pharmaceuticals, Inc. FUSN 515.34 None 1.62 -7.87 None
Oyster Point Pharma, Inc. OYST 508.56 None 2.28 -7.95 None
Aprea Therapeutics, Inc. APRE 488.88 None 4.92 -10.93 None
AMAG Pharmaceuticals, Inc. AMAG 466.14 298.00 1.90 -1.80 -86.95
Inozyme Pharma, Inc. INZY 464.40 None -10.85 -16.95 None
Odonate Therapeutics, Inc. ODT 461.90 None 5.44 -3.91 None
TCR2 Therapeutics, Inc. TCRR 459.36 None 4.78 -9.43 None
G1 Therapeutics, Inc. GTHX 424.84 2.00 2.09 -3.23 None
Mirum Pharmaceuticals, Inc. MIRM 415.25 None 3.10 -5.36 None
Tricida, Inc. TCDA 413.50 None 1.79 -1.75 None
Applied Therapeutics, Inc. APLT 402.23 14.00 3.65 -5.77 -19.41
DURECT Corp. DRRX 354.22 50.00 9.89 -178.00 -3.66
89bio, Inc. ETNB 336.28 None 7.02 -5.50 None
Sutro Biopharma, Inc. STRO 333.58 40.00 2.23 -15.09 -43.34
Crinetics Pharmaceuticals, Inc. CRNX 320.84 1.00 2.00 -5.12 -447.78
Osmotica Pharmaceuticals Plc OSMT 294.25 212.00 2.61 -1.82 -73.47
KalVista Pharmaceuticals, Inc. KALV 288.36 9.00 3.85 -8.75 -349.66
Relmada Therapeutics, Inc. RLMD 284.85 0.00 3.84 -23.80 -877.66
Kala Pharmaceuticals, Inc. KALA 272.65 5.00 2.89 -2.96 None
Imara, Inc. IMRA 272.51 None 2.61 -7.09 None
Fulcrum Therapeutics, Inc. FULC 264.33 3.00 2.20 -3.95 None
Ovid Therapeutics, Inc. OVID 258.00 None 10.75 -3.37 None
TFF Pharmaceuticals, Inc. TFFP 254.03 None 13.37 -6.34 None
Spero Therapeutics, Inc. SPRO 251.37 12.00 4.66 -3.03 -713.29
Lannett Co., Inc. LCI 249.21 546.00 0.85 -7.43 -6.11
IDEAYA Biosciences, Inc. IDYA 247.00 None 2.08 -56.14 None
HOOKIPA Pharma, Inc. HOOK 242.32 16.00 2.30 -9.23 -247.22
Galera Therapeutics, Inc. GRTX 239.50 None 5.91 -3.39 None
Urovant Sciences Ltd. UROV 238.70 None -2.83 -1.58 None
Kaleido Biosciences, Inc. KLDO 203.05 0.00 4.55 -2.62 None
Immunic, Inc. IMUX 189.53 None 4.53 -6.58 None
Verrica Pharmaceuticals, Inc. VRCA 185.75 None 3.95 -5.63 None
Ayala Pharmaceuticals, Inc. AYLA 166.53 3.00 3.04 -6.81 -728.78
scPharmaceuticals, Inc. SCPH 158.40 119.00 2.21 -4.89 -27.05
Veru, Inc. VERU 155.76 40.00 4.00 -14.75 -25.78
Aquestive Therapeutics, Inc. AQST 154.50 59.00 -8.05 -2.93 -84.20
Xeris Pharmaceuticals, Inc. XERS 151.59 6.00 9.23 -1.23 None
NeuBase Therapeutics, Inc. NBSE 150.66 None 5.58 -2.80 None
Lyra Therapeutics, Inc. LYRA 149.50 1.00 1.71 -8.46 -491.16
Evelo Biosciences, Inc. EVLO 145.92 None 3.04 -1.67 None
Eton Pharmaceuticals, Inc. ETON 143.83 1.00 26.10 -6.76 None
Milestone Pharmaceuticals, Inc. MIST 139.25 None 1.56 -4.57 None
Harrow Health, Inc. HROW 127.66 45.00 8.05 -5.71 -48.54
LogicBio Therapeutics, Inc. LOGC 126.04 2.00 6.16 -3.13 None
Mustang Bio, Inc. MBIO 115.92 None 2.19 -2.16 None
Liquidia Technologies, Inc. LQDA 112.80 8.00 20.43 -1.90 -589.48
Corvus Pharmaceuticals, Inc. CRVS 110.20 None 2.10 -2.45 None
ESSA Pharma, Inc. EPIX 108.68 None 4.50 -8.67 None
Protara Therapeutics, Inc. TARA 108.42 None 3.20 -3.61 None
Tyme Technologies, Inc. TYME 105.49 None 7.45 -3.89 None
Checkpoint Therapeutics, Inc. CKPT 104.85 1.00 10.59 -4.48 -873.97
Gritstone Oncology, Inc. GRTS 99.00 4.00 1.08 -0.93 None
Evolus, Inc. EOLS 95.79 51.00 2.40 -1.17 -161.74
VYNE Therapeutics, Inc. VYNE 92.91 13.00 3.79 -0.42 -483.51
Lantern Pharma, Inc. LTRN 91.02 None 4.06 -35.28 None
PhaseBio Pharmaceuticals, Inc. PHAS 79.46 1.00 3.04 -1.19 None
ProPhase Labs, Inc. PRPH 77.52 11.00 6.87 -46.14 -14.31
Menlo Therapeutics, Inc. MNLO 76.95 13.00 3.14 -0.35 -483.51
Genprex, Inc. GNPX 74.16 None 4.90 -5.24 None
AgeX Therapeutics, Inc. AGE 71.44 2.00 -31.33 -5.87 -625.09
AgeX Therapeutics, Inc. AGE 66.50 2.00 -29.17 -5.47 -625.09
BiomX, Inc. PHGE 65.45 None 1.87 -1.53 None
Cyclerion Therapeutics, Inc. CYCN 63.00 5.00 1.15 -0.67 None
Satsuma Pharmaceuticals, Inc. STSA 61.54 None 0.67 -1.50 None
Eyenovia, Inc. EYEN 60.48 None 9.88 -3.08 None
Clearside Biomedical, Inc. CLSD 58.05 7.00 8.44 -3.29 -280.03
Aridis Pharmaceuticals, Inc. ARDS 57.42 1.00 -9.38 -2.38 -851.00
Edesa Biotech, Inc. EDSA 55.60 0.00 11.03 -0.59 -395.23
Trevi Therapeutics, Inc. TRVI 55.44 None 1.41 -3.62 None
Assertio Holdings, Inc. ASRT 55.19 156.00 0.83 -0.26 -117.10
Aerpio Pharmaceuticals, Inc. ARPO 53.30 15.00 1.29 -14.44 -24.91
Navidea Biopharmaceuticals, Inc. NAVB 49.80 1.00 -27.67 -4.79 -65.13
Adamis Pharmaceuticals Corp. ADMP 49.40 20.00 3.04 -1.49 -170.82
Avenue Therapeutics, Inc. ATXI 48.16 532.00 12.04 -4.78 26.69
EyePoint Pharmaceuticals, Inc. EYPT 43.32 23.00 12.67 -0.83 -229.33
Akari Therapeutics Plc AKTX 36.18 None -33.50 -2.01 None
Moleculin Biotech, Inc. MBRX 36.00 None 2.88 -1.89 None
Aileron Therapeutics, Inc. ALRN 34.80 None 2.86 -1.33 None
Annovis Bio, Inc. ANVS 33.95 None 3.51 -10.32 None
Mannatech, Inc. MTEX 33.90 153.00 1.45 9.02 2.96
Allena Pharmaceuticals, Inc. ALNA 32.25 None 2.69 -0.81 None
Citius Pharmaceuticals, Inc. CTXR 32.00 None 1.92 -1.85 None
Acer Therapeutics, Inc. ACER 26.40 3.00 2.81 -1.27 -274.69
CNS Pharmaceuticals, Inc. CNSP 26.25 None 7.95 -3.50 None
Oncternal Therapeutics, Inc. ONCT 24.32 2.00 3.45 1.79 -778.44
Millendo Therapeutics, Inc. MLND 23.68 0.00 0.64 -0.50 None
Akorn, Inc. AKRX 22.68 721.00 -1.20 -0.06 -55.64
Novan, Inc. NOVN 20.77 5.00 -0.47 -0.58 -572.98
Daré Bioscience, Inc. DARE 20.48 1.00 97.52 -1.15 None
Sun BioPharma, Inc. SNBP 19.53 1.00 16.41 -4.23 -7.89
Baudax Bio, Inc. BXRX 19.08 0.00 -0.33 -0.22 None
Hoth Therapeutics, Inc. HOTH 19.03 None 3.39 -1.78 None
Adial Pharmaceuticals, Inc. ADIL 19.03 None 2.70 -2.37 None
Spring Bank Pharmaceuticals, Inc. SBPH 18.36 0.00 0.80 -0.62 None
Novus Therapeutics, Inc. NVUS 17.49 None 2.34 -0.85 None
PDS Biotechnology Corp. PDSB 17.19 None 2.51 -0.72 None
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Titan Pharmaceuticals, Inc. TTNP 10.37 5.00 17.00 -1.55 -351.69
Brickell Biotech, Inc. BBI 3.57 10.00 0.84 -0.16 -165.28
BioStar Pharmaceuticals, Inc. BSPM 0.21 0.00 0.01 0.10 294.01

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Reata Announces Publication of Results From Pivotal Moxie Trial of Omaveloxolone in Patients with Friedreich’s Ataxia

2d ago, source: YAHOO!

PLANO, Texas, Oct. 26, 2020 (GLOBE NEWSWIRE) -- (Nasdaq: RETA) (“Reata,” the “Company,” or “we”), a clinical-stage biopharmaceutical company, today announced that results from the pivotal part 2 port ...

ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Reata Pharmaceuticals, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $ ...

2d ago, source: Business Wire

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Reata Pharmaceuticals, Inc. (NASDAQ: RETA) between October 15, 2019 and August 7, ...

REATA PHARMACEUTICALS, INC. CLASS ACTION LAWSUIT – Reata Investors Who Have Suffered Losses ...

12d ago, source: Associated Press

Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Reata Pharmaceuticals, Inc. (“Reata” or the “Company”) ( NASDAQ: RETA) to determine whether the Company ...

Lawsuit filed for Investors in Reata Pharmaceuticals, Inc. (NASDAQ: RETA) shares

8d ago, source: openpr.com

An investor, who purchased shares of Reata Pharmaceuticals, Inc. (NASDAQ: RETA), filed a lawsuit iover alleged violations of Federal Securities Laws by Reata Pharmaceuticals, Inc. Investors who ...

Reata Pharmaceuticals, Inc. Announces Presentation of KIDNEYCODE Program at the American ...

13d ago, source: Associated Press

(GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (“Reata” or “the Company” or “we”) announced today the upcoming presentation of KIDNEYCODE: A Genetic Testing Program for Patients with Chronic Kidney ...

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Reata Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess ...

12d ago, source: Business Wire

The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Reata Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of ...

Reata Pharmaceuticals, Inc. Announces Presentation of KIDNEYCODE Program at the American Society of Nephrology Kidney Week 2020 Reimagined

7d ago, source: Business Insider

Disclaimer | Commerce Policy | Made In NYC | Stock quotes by finanzen.net PLANO, Texas, Oct. 15, 2020 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (“Reata” or “the Company” or “we ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.